Staying Alive: Lymphoma Survival Rate

There are a lot of factors that affect the lymphoma survival rate which is why its different in case to case. To calculate the survival rate of the patient the main variables are the age, the time of detection or diagnosis, and the health of the individual. Another significant thing to consider it the type of lymphoma the person is identified with.

Lymphoma is a cancer that is present as a solid tumor in the lymph nodes. It deteriorates the body’s immune and lymphatic system. The lymphocytes grow tumors if an individual is badly affected by lymphoma. These tumors can reproduce and build up in great number going to the nearby tissues and not allowing it of essential nutrients and oxygen. The lymphomas can journey to other tissues and other parts of the organ if the cancer is already at an advanced stage.

About 85% of people in stages one and two live for five years after detection of cancer, given that there is proper treatments involved, this is according to the American Cancer Society. The Lymphoma survival rate of a person relies on the factors that include the patient’s overall health, the stages of the illness, and the treatment administered.

There are various ways to treat lymphoma like chemotherapy, radiation therapy, and sometimes bone marrow transplants. These treatments must be done with precaution because even though it is effective it may cause damages or side effects to organs like the liver, kidney, heart, and brain. Treatments may be discontinued or may not be effective if the patient cannot tolerate the side effects of the intense therapy whose purpose is to stop the disease from advancing. The patient’s lymphoma survival rate will not only rely on the treatment but the age factor and type of lymphoma as well. Those who are young have higher lymphoma survival rate, which is about 90%.

Because of the advances of technology, innovation and radical approaches to therapy the chances of higher lymphoma survival rate has become possible over the past decades. For adults, the five-year survival rate after treatment is round 63% but it is higher for children, which is 90%. The addition of immunotherapy to standard treatment may further improve the prevailing lymphoma survival rates.